Figure 1
From: Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Targeting strategies in self-renewal pathways in CSCs including their pharmacological antagonists and different nanoparticles used for formulation. (1) Hh ligand Inhibitors (2) GLI Antagonists (3) SMO Inhibitors (4) Anti-DLL4 Antibodies (5) γ –Secretase Inhibitors (6) MAML Inhibitors (7) Anti-FZD Antibodies (8) Wnt Ligand inhibitors (9) Wnt Transcription Complex Inhibitors (10) HDAC Inhibitors.
